Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Vijaya Diagnostic Centre Ltd Q1FY24; 44% rise in Profits
Categories
Diagnostics
Metropolis Healthcare Ltd Q1FY24; 15% fall in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Thyrocare Technologies Ltd Q1FY24; 5% fall in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Metropolis Healthcare Q4FY23 Earnings Story
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Vijaya Diagnostics Centre Ltd Q4FY23 results out, revenue grows by 4%
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Dr Lal PathLabs Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:17:48] Rahul Agarwal from InCred Capital asked if
Earnings | Dr Lal Path Labs Ltd (NSE:LALPATHLAB): Q3FY23 Results Out; Total Income fell 2% YoY
Dr Lal Path Labs Ltd (NSE:LALPATHLAB) is a leading diagnostic services provider in India. The company was founded in 1949 by Dr.
Vijaya Diagnostic Q3FY23 net profit drops by 35 percent
Vijaya Diagnostic reported total income of INR 116.67 crores during the period ended December 31, 2022 as compared to INR 113.97 crores
Earnings Summary Of Fortis Healthcare Limited For Q3 FY23
Fortis Healthcare Limited (NSE: FORTIS) is one of India's leading healthcare providers, offering a range of medical services across its network of
Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year
Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the previous year.
Thyrocare Technologies net profit declines by 43% in the December 2022 quarter
Net profit of Thyrocare Technologies declined by 43.47% to INR 13 crore in the quarter ended December 2022 as against INR 23
Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked about the
Vijaya Diagnostic: A King in the Making
“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to enhance its
Krsnaa Diagnostics Ltd (KRSNAA) Q2 FY23 Earnings Concall Transcript
Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Yash Prithviraj Mutha C.A. -- Whole-Time Director Pawan
Dr Lal PathLabs Ltd Q2 FY23 Earnings Conference Call Insights
https://youtu.be/lAaNZKEvjOc Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred Capital enquired
Earnings Infographic: Dr. Lal PathLabs Q1 2023 revenue and profit decline
Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and earnings for
Dr Lal PathLabs Limited Research Report
Stock Data Ticker: LALPATHLAB Exchange : NSE BSE: 539524 Industry: Diagnostic Price Performance Last 7 days 8.70% YTD -38.28% Last 12 months
Dr Lal PathLabs Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/GyHJJGLWdjg Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Management Update: LALPATHLAB said it clocked the highest quarterly
Research Summary Dr Lal PathLabs Limited Q4 FY 2022
Overview Dr Lal PathLabs Limited is an Indian diagnostic company. It was incorporated in 1949. The headquarters is situated in Delhi, India. It
Krsnaa Diagnostics Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/oafWwDciC8w Key highlights from Krsnaa Diagnostics Ltd (KRSNAA) Q4 FY22 Earnings Concall Q&A Highlights: Praveen Sahay of Edelweiss asked that why the
Dr Lal PathLabs Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant shift towards